Akting up in the GABA hypothesis of schizophrenia: Akt1 deficiency modulates GABAergic functions and hippocampus-dependent functions
Male
Mice, Knockout
Pyramidal Cells
Cell Count
Cell Differentiation
Convulsants
Receptors, GABA-A
Brain Waves
Hippocampus
Article
GABA Antagonists
03 medical and health sciences
Parvalbumins
0302 clinical medicine
Interneurons
Schizophrenia
Animals
Pentylenetetrazole
Female
Schizophrenic Psychology
GABAergic Neurons
Maze Learning
Proto-Oncogene Proteins c-akt
DOI:
10.1038/srep33095
Publication Date:
2016-09-12T10:18:09Z
AUTHORS (4)
ABSTRACT
Accumulating evidence implies that both AKT1 and GABAA receptor (GABAAR) subunit genes are involved in schizophrenia pathogenesis. Activated Akt promotes GABAergic neuron differentiation increases GABAAR expression on the plasma membrane. To elucidate role of Akt1 modulating functions schizophrenia-related cognitive deficits, a set 6 vitro vivo experiments was conducted. First, an Akt1/2 inhibitor applied to evaluate its effect neuron-like cell formation from P19 cells. Inhibiting resulted reduction parvalbumin-positive In Akt1(-/-) wild-type mice, seizures induced using pentylenetetrazol (a antagonist) were measured, interneuron abundance brain examined. Female but not male exhibited less pentylenetetrazol-induced convulsive activity than their corresponding controls. Reduced expression, especially hippocampus, also observed female mice compared mice. Neuromorphometric analyses revealed significantly reduced neurite complexity hippocampal pyramidal neurons. Additionally, displayed increased oscillation power impaired spatial memory Our findings suggest deficiency modulates interneurons contributing hippocampus-dependent functional impairment.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (58)
CITATIONS (18)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....